Nanopore Diagnostics is developing a rapid and portable bacterial diagnostic assay.

Our test will allow a physician to make an informed antibiotic decision during their initial examination of a patient, ensuring antibiotics are only administered when truly needed. Our core technology for counting specific nucleic acid biomarkers is quicker, simpler, and more accurate than current methods.

For more information, follow :

Financials

  • $600k